Brunswick Corporation (NYSE:BC), the world’s largest marine technology company, delivered an award-winning performance at the 2026 Düsseldorf Boat Show, highlighting its continued leadership in the ...

Game to Watch: Tuesday at Jazz (NBC/Peacock): The Clippers are an NBA-best 10-3 in January and have won 15 of their last 18 games overall. They will look to stay hot and continue to climb the West ...

CHESTNUT HILL, Mass. — Boston College women’s basketball was dealt a 73-58 setback on Sunday afternoon to California. The Eagles drop to 4-17 and 0-7 in the ACC, while the Golden Bears improve to 11-9 ...

Despite being outshot 46-19 by the Eagles, the Friars capitalized on multiple defensive turnovers in front of the goal, with goaltender Jack Parsons anchoring the effort in net. The Friars defeated ...

Ever since the official cast of “Survivor 50: In the Hands of the Fans” was announced by CBS in May 2025, longtime fans of the hit reality competition series have been commiserating over the fact that ...

The Boston Bruins host the Seattle Kraken at TD Garden on Thursday, Jan. 15 at 8 p.m. ET. The game airs on ESPN+. Boston won 3-0 at home its last time out on Jan. 13 against the Detroit Red Wings.

Time Out Market in Boston will shutter this month, nearly seven years after opening in the city's Fenway neighborhood, the company said, citing financial difficulties. The 27,000-square-foot food hall ...

Boston Scientific said on Thursday it will buy ⁠medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular devices, in the largest acquisition by the ...

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio. Boston Scientific on Thursday said the ...

Jan 15 (Reuters) - Boston Scientific ‌agreed to buy medtech firm Penumbra in ‌a $14.5 billion deal on Thursday, its second‑largest takeover ever, as it looks to re-enter the neurovascular market and ...

Jan 15 (Reuters) – Boston Scientific said on ‍Thursday it will buy Penumbra in a deal ‌valued at ‌about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, ‍a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific Corp. is ...